These products are sold for research purposes and require users to take responsibility for their own decisions regarding use
Victoza for diabetes (up to 1.8 mg), Saxenda for weight management (up to 3 mg) Oral GLP-1 option : Semaglutide (Rybelsus) is the only oral GLP-1 receptor agonist, taken once daily on an empty stomach with specific administration requirements: take with no more than 4 ounces of plain water, at least 30 minutes before eating, drinking, or taking other oral medications, and swallow tablets whole without breaking or chewing
Medicare currently does not cover GLP-1s for weight loss alone but may cover for the CV-reduction indication in eligible patients
It is studied for its ability to stimulate melanogenesis (skin tanning), influence libido, and activate melanocortin receptors in the brain and skin
It also has a higher rate of side effects, particularly nausea and diarrhea